The race by large retailers and tech giants to expand and strengthen their positions in the primary care market continues at a rapid pace
Combined with a number of recent acquisitions and ongoing consolidation by market participants, we view the primary care market undergoing a major transformation over the next few years.
AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond
Amazon’s recent purchase of OneMedical is not generically about primary care – or even direct primary care. It’s about Medicare. Specifically, Medicare Advantage.
Idorsia Ltd. and Syneos Health® announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the treatment of insomnia across Europe and Canada
The FDA approved Paratek’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with Community-Acquired Bacterial Pneumonia (CABP)
The Care Accelerator launched last year which was only the beginning of Sam’s Club’s increased involvement in health care
Humana plans to serve as a partner in health and aging, delivering a personalized and simple experience through an integrated, value-based health ecosystem